Outcome of kidney transplantation from high-risk donors is determined by both structure and function

…, G Lajoie, D Cattran, S Fenton, J Zaltzman… - …, 1999 - journals.lww.com
Method. Despite the need to expand the donor pool, it is unclear what parameters should
be used. The value of donor renal pathology and calculated creatinine clearance (CrCl) in …

Kidney transplantation in the elderly: a decision analysis

…, MD Krahn, G Naglie, JS Zaltzman… - Journal of the …, 2003 - journals.lww.com
ABSTRACT. Transplantation offers superior life expectancy and quality of life compared with
dialysis in young patients with end-stage renal failure. However, the initial risks of mortality …

COVID-19 outbreak in an urban hemodialysis unit

…, A Thomas, JJ Weinstein, J Zaltzman… - American Journal of …, 2020 - Elsevier
Rationale & Objective Hemodialysis patients are at increased risk for coronavirus disease
2019 (COVID-19) transmission due in part to difficulty maintaining physical distancing. Our …

Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in chronically immunosuppressed adults following renal transplant: a phase 3, randomized …

…, SJ Kim, S Kim, J Zaltzman… - Clinical Infectious …, 2020 - academic.oup.com
Background The incidence of herpes zoster is up to 9 times higher in immunosuppressed
solid organ transplant recipients than in the general population. We investigated the …

ACE inhibitors and angiotensin II antagonists in renal transplantation: an analysis of safety and efficacy

CE Stigant, J Cohen, M Vivera, JS Zaltzman - American journal of kidney …, 2000 - Elsevier
Angiotensin-converting enzyme inhibitors (ACEi) are a class of antihypertensive agents that
decrease mortality in congestive heart failure and have established efficacy in the treatment …

Levofloxacin for BK virus prophylaxis following kidney transplantation: a randomized clinical trial

…, SJ Kim, T Ramsay, M Chassé, X Pang, J Zaltzman… - Jama, 2014 - jamanetwork.com
Importance BK virus infection is a significant complication of modern immunosuppression
used in kidney transplantation. Viral reactivation occurs first in the urine (BK viruria) and is …

Outcomes of commercial renal transplantation: a Canadian experience

…, A Shukla, M Huang, RJDA Honey, JS Zaltzman - …, 2006 - journals.lww.com
Background. Financial compensation in exchange for live kidney donation is prohibited in
Canada. However, patients in Canada with end-stage renal disease and without a suitable …

Community-acquired West Nile virus infection in solid-organ transplant recipients

D Kumar, GVR Prasad, J Zaltzman, GA Levy… - …, 2004 - journals.lww.com
Background. West Nile virus (WNV) is rapidly spreading through North America. In the general
population, the majority of WNV infections are asymptomatic. During 2002, an outbreak of …

Impact of kidney transplantation on sleep apnoea in patients with end-stage renal disease

JM Beecroft, J Zaltzman, R Prasad… - Nephrology Dialysis …, 2007 - academic.oup.com
Background. Sleep apnoea is common in patients with end-stage renal disease. Although
individual case reports have described an improvement in sleep apnoea following kidney …

A pilot study of steroid-free immunosuppression in the prevention of acute rejection in renal allograft recipients

E Cole, D Landsberg, D Russell, J Zaltzman… - …, 2001 - journals.lww.com
Background. Corticosteroids have been a mainstay of rejection prophylaxis for several
decades, despite the multiple adverse effects of long-term use, including weight gain, …